CHROMOSOMAL ABERRATIONS IN LEUKOCYTE METAPHASES OF LEPROSY PATIENTS UNDER DAPSONE THERAPY
Vol. 1 No. 1 (1976), Artigos de investigação científica
Vol. 1 No. 1 (1976)

CHROMOSOMAL ABERRATIONS IN LEUKOCYTE METAPHASES OF LEPROSY PATIENTS UNDER DAPSONE THERAPY

Artigos de investigação científica
https://doi.org/10.47878/hi.1976.v1.35675
Published 1976-06-30
B. BEIGUELMAN
Department of Medical Genetics, State University of Campinas, SP, Brasil.
R. C. B. PISANI
Department of Medical Genetics, State University of Campinas, SP, Brasil.
PDF (Português (Brasil))

Keywords

Hanseniasis
Therapy
Dapsone
Genetics
Chromosome analysis
Chromosomal aberrations

How to Cite

1.
BEIGUELMAN B, PISANI RCB. CHROMOSOMAL ABERRATIONS IN LEUKOCYTE METAPHASES OF LEPROSY PATIENTS UNDER DAPSONE THERAPY . Hansen. Int. [Internet]. 1976 Jun. 30 [cited 2024 Nov. 21];1(1):53-60. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/35675
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Chromosome analyses were made on leukocyte metaphases of 18 leprosy patients who were ingesting daily doses of 50 mg or 100 mg of DDS and of 40 healthy individuals used for control. These analyses have shown that the proportion of numerical chromosomal aberrations in the leukocyte metaphases of the leprosy patients did not differ significantly from that observed in the cells of the controls. In contrast, the frequency of cells with chromatid or chromosome breaks and gaps was significantly increased in the leukocytes of leprosy patients. Multiple regression analysis applied to the data recorded has shown that the increase of breaks and gaps in the chromosomes of leprosy patients can not be attributed to age, years under sulfonetherapy or to concentration of DDS in blood.

https://doi.org/10.47878/hi.1976.v1.35675
PDF (Português (Brasil))

References

1. BEIGUELMAN, B.; MARCHI, A.; HAMA, T.; AMIN, C.C.; GODOI, M. N. C.; BAPTISTA, T. A. Fecundidade e lepra. Rev. Paul. Med., 66(4) : 207-213, 1965.
2. BEIGUELMAN, B.; PINTO JR., W.; EL-GUINDY, M. M.; KRIEGER, H. Factors influencing the level of dapsone in blood. Bull. World Health Organ., 51 :467-471, 1974.
3. BEIGUELMAN, B.; PISANI, R. C. B.; EL-GUINDY, M. M. In vitro effect of DDS on human chromosomes. Int. J. Leprosy, 48(1):41-44, 1975.
4. BLOOM, A. D. Induced chromosomal aberrations in man. In: HARRIS, H. & HIRSCHHORN, K., ed. Advances in human genetics. New York, Plenum Press, 1972. cap. 3, p. 99-172.
5. BLOOM, A. D.; NEEL, J. V.; TSUCHIMOTO, T.; MEILINGER, K. Chromosomal breakage in leukocytes of South American Indians. Cytogenetics, 12:175-186, 1973.
6. COURT-BROWN, W. M. Human population cytogenetics. Amsterdam, North- Holland Publ., 1967. 107p.
7. LUBS, H. A. & SAMUELSON, H. A. Chromosome abnormalities in lymphocytes from normal human subjects. Cytogenetics, 6:402-411, 1967.
8. MOLESWORTH, B. D.; NARAYANASWAMI, P. S.; SIMPSON, I. A. The treatment of lepromatous leprosy with 4:4'-Diaminodiphenyl sulfone in oil: findings in 100 cases treated for one year, with a note on the technique of sulfone determinations. Int. J. Leprosy, 17(3) :197-210, 1949.
9. NICHOLS, W. W. Virus-induced chromosome abnormalities. Ann. Rev. Microbiol., 24:479-500, 1970.
10. RABELLO, M.N. Estudo citogenético de indivíduos profissionalmente expostos ao DDT. São Paulo, 1974. 142p. [Tese-Universidade de São Paulo]

This journal is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.